Join
Live feed
·
INSIDERFilingvia Quantisnow
Harpoon Therapeutics Inc. logo

Chin Mark returned 13,224 shares to the company and was granted 424 shares, closing all direct ownership in the company (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
HARP· Harpoon Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track HARP (Harpoon Therapeutics Inc.) and more on Quantisnow.